685 related articles for article (PubMed ID: 29740706)
21. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis.
Zeng Q; Wang WR; Li YH; Liang Y; Wang XH; Yan L; Yu RH
Front Immunol; 2023; 14():1209394. PubMed ID: 37671165
[TBL] [Abstract][Full Text] [Related]
23. IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
Hastings MC; Rizk DV; Kiryluk K; Nelson R; Zahr RS; Novak J; Wyatt RJ
Pediatr Nephrol; 2022 Apr; 37(4):719-733. PubMed ID: 33818625
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
[TBL] [Abstract][Full Text] [Related]
26. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
27. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
28. Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
Sun Q; Zhang Z; Zhang H; Liu X
PLoS One; 2016; 11(11):e0166700. PubMed ID: 27870872
[TBL] [Abstract][Full Text] [Related]
29. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
Reily C; Ueda H; Huang ZQ; Mestecky J; Julian BA; Willey CD; Novak J
J Immunol Res; 2014; 2014():197548. PubMed ID: 25152896
[TBL] [Abstract][Full Text] [Related]
30. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
31. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
Cambier A; Dossier C; Hogan J; Baudouin V; Maisin A; Couderc A; Kwon T; Gleeson PJ; Monteiro RC
Pediatr Nephrol; 2022 Jul; 37(7):1597-1603. PubMed ID: 34997322
[TBL] [Abstract][Full Text] [Related]
32. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
Hastings MC; Moldoveanu Z; Julian BA; Novak J; Sanders JT; McGlothan KR; Gharavi AG; Wyatt RJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2069-74. PubMed ID: 20634323
[TBL] [Abstract][Full Text] [Related]
33. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
34. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Kim MJ; Schaub S; Molyneux K; Koller MT; Stampf S; Barratt J
PLoS One; 2016; 11(12):e0166830. PubMed ID: 27930655
[TBL] [Abstract][Full Text] [Related]
35. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
Novak J; Julian BA; Mestecky J; Renfrow MB
Semin Immunopathol; 2012 May; 34(3):365-82. PubMed ID: 22434325
[TBL] [Abstract][Full Text] [Related]
36. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Camilla R; Suzuki H; Daprà V; Loiacono E; Peruzzi L; Amore A; Ghiggeri GM; Mazzucco G; Scolari F; Gharavi AG; Appel GB; Troyanov S; Novak J; Julian BA; Coppo R
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1903-11. PubMed ID: 21784819
[TBL] [Abstract][Full Text] [Related]
38. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
39. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
[TBL] [Abstract][Full Text] [Related]
40. IgA glycosylation and immune complex formation in IgAN.
Suzuki H; Novak J
Semin Immunopathol; 2021 Oct; 43(5):669-678. PubMed ID: 34570260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
